Public Health Webinar Series on Blood Disorders
CDC’s Division of Blood Disorders (DBD) is proud to offer its “Public Health Webinar Series on Blood Disorders.” The purpose of this series is to provide evidence-based information on new research, interventions, emerging issues of interest in blood disorders, as well as innovative approaches in collaborations and partnerships. We invite you to join us in this series.
Archives for 2016
April 21, 2016
Margaret Ragni, MD, MPH
“Update on Treatment of Hepatitis C in People with Hemophilia”
March 3, 2016
Alex Spyropoulos, MD, FACP, FCCP, FRCP
“Assessing the Risk for Venous Thromboembolism in Hospitalized Medical Patients”
February 18, 2016
Mike Soucie, PhD
“Impact of Public Health Surveillance on Hemophilia Care”
Archives for 2015
October 13, 2015
Andra James, MD, MPH
“Prevention and Treatment of VTE at the Time of Childbirth”
September 24, 2015
Connie Miller, PhD
“Diagnosis and Treatment of von Willebrand Disease: Challenges and Opportunities”
March 19, 2015
Greg Maynard, MD, MSc, SFHM
"Preventing Hospital-Associated Venous Thromboembolism: Practical Strategies that Work". In this presentation, Dr. Maynard discussed key issues and opportunities for reducing hospital-associated venous thromboembolism.
January 22, 2015
Andra H. James, MD
"Reproductive Issues in Women with Bleeding Disorders". In this webinar, Dr. James discussed key issues for women of reproductive age who have bleeding disorders.
Archives for 2014
November 6, 2014
"Venous Thromboembolism: Recent Advances in Reducing the Disease Burden"
Gary E. Raskob, PhD, MSc
In this webinar, Dr. Raskob reviewed the disease burden from venous thromboembolism. He also discussed strategies to reduce this burden through the prevention of first time and recurrent blood clots.
July 10, 2014
"Vitamin K and Vitamin K Deficiency Bleeding in Infants"
Lauren Marcewicz, MD
In this presentation, Dr. Marcewicz reviewed how vitamin K works in infants, discussed the different classifications of vitamin K deficiency bleeding, and explained how to talk with parents about the administration of this important public health measure. To access the slides from this presentation, please click here.
July 24, 2014
"Inhibitor Testing: State of the Art"
Connie Miller, PhD
In this presentation, Dr. Miller described the development of inhibitors in people who have hemophilia. She described different methods available for inhibitor testing and discussed the CDC laboratory's role in national inhibitor monitoring.
April 3, 2014
"New Challenges in Hemophilia”
Guy Young, MD
Director, Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles
Associate Professor of Pediatrics at the University of Southern California Keck School of Medicine
In this presentation, Dr. Young described many new changes that are coming to the field of hemophilia during the next few years, including new treatment strategies, new issues concerning bone health, and impacts of overweight and obesity. Dr. Young also addressed specific challenges for people with hemophilia who have an inhibitor.
March 6, 2014
"Understanding Deep Vein Thrombosis: What Everyone Needs to Know”
Beth Waldron, MA
Program Director, Clot Connect
University of North Carolina at Chapel Hill
In this presentation, Beth Waldron presented the risk factors, symptoms, treatment, prevention strategies, and her personal experience with deep vein thromboembolism and pulmonary embolism.
February 6, 2014
"Venous Thromboembolism and Cancer”
Alok Khorana, MD
Director of the Gastrointestinal Malignancies Program at Taussig Cancer Institute of the Cleveland Clinic.
In this presentation, Dr. Khorana detailed the prevalence, consequences, and costs of venous thromboembolism (VTE) and described the importance of both predicting and preventing VTE in people who have cancer.
- Page last reviewed: June 23, 2016
- Page last updated: June 23, 2016
- Content source: